Ava Leegant, MD
Urogynecology and Reconstructive Pelvic Surgery · Bronx, NYNPI 1598892945
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,035 of the $3,198 with a category attached, or 63.6%. 7 manufacturers reported payments, led by Axonics, Inc. at 42.3% of the total.
Across 42 payments — averaging $76.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$1K
- Applied Medical Resources Corporation$765
- Boston Scientific$548
- Intuitive Surgical$252
- Medtronic$169
- Coloplast$60
- plus $52 from 1 others
What the payments were for
- Travel & lodging$1,16336%
- Food & beverage$2,03564%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 19 | $1,351 |
| Applied Medical Resources Corporation | 5 | $765 |
| Boston Scientific | 7 | $548 |
| Intuitive Surgical | 5 | $252 |
| Medtronic(2 entities) | 3 | $169 |
| Coloplast | 1 | $60 |
| AbbVie | 2 | $52 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GelPOINT V-Path$614
- Axonics$482
- Bulkamid$412
- Da Vinci Surgical System$205
- Advantage System$170
- Solyx SIS System$167
How this compares
$3,198 in reported general payments places this provider in the 55th percentile of 90 urogynecology and reconstructive pelvic surgery providers in New York.
See all urogynecology and reconstructive pelvic surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 60 | $31,583 |
| MyrbetriqMirabegron | 54 | $24,323 |
| Estradiol | 106 | $5,364 |
| Trospium Chloride | 28 | $1,021 |
| Trospium Chloride ErTrospium Chloride | 12 | $759 |
| Metronidazole | 12 | $356 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $68 |
| Ciprofloxacin Hcl | 14 | $64 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 27 | $40 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Bronx
- Nitya AbrahamBronx$24K
- Jason KimStony Brook$346K
- Dara ShalomGreat Neck$94K
- Harvey WinklerGreat Neck$81K
- Robert MoldwinNew Hyde Park$35K
- Cornelius VerhoestPoughkeepsie$21K
- Abeer EddibCheektowaga$19K
- Wai LeeNew Hyde Park$17K
- Doreen ChungNew Hyde Park$14K
- Jennifer HillRiverhead$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.